These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas. Krawczyk A, Hasse-Lazar K, Pawlaczek A, Szpak-Ulczok S, Krajewska J, Paliczka-Cieślak E, Jurecka-Lubieniecka B, Roskosz J, Chmielik E, Ziaja J, Cierpka L, Peczkowska M, Preibisz A, Januszewicz A, Otto M, Jarzab B. Endokrynol Pol; 2010; 61(1):43-8. PubMed ID: 20205103 [Abstract] [Full Text] [Related]
23. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. Beldjord C, Desclaux-Arramond F, Raffin-Sanson M, Corvol JC, De Keyzer Y, Luton JP, Plouin PF, Bertagna X. J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256 [Abstract] [Full Text] [Related]
24. Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma. Nakamura E, Kaelin WG. Endocr Pathol; 2006 Jul; 17(2):97-106. PubMed ID: 17159241 [Abstract] [Full Text] [Related]
26. [Genetics of paragangliomas and pheochromocytomas]. Favier J, Gimenez-Roqueplo AP. Med Sci (Paris); 2012 Jul 29; 28(6-7):625-32. PubMed ID: 22805139 [Abstract] [Full Text] [Related]
27. Absence of mutations at codon 768 of the RET proto-oncogene in sporadic and hereditary pheochromocytomas. Yoshimoto K, Kimura T, Tanaka C, Moritani M, Iwahana H, Itakura M. Endocr J; 1996 Feb 29; 43(1):109-14. PubMed ID: 8732460 [Abstract] [Full Text] [Related]
28. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma. Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Solórzano CC, Kim LT. Ann Surg Oncol; 2020 May 29; 27(5):1329-1337. PubMed ID: 32112212 [Abstract] [Full Text] [Related]
29. Genetics of pheochromocytomas and paragangliomas. Opocher G, Schiavi F. Best Pract Res Clin Endocrinol Metab; 2010 Dec 29; 24(6):943-56. PubMed ID: 21115163 [Abstract] [Full Text] [Related]
30. The RET proto-oncogene in sporadic pheochromocytomas. Takaya K, Yoshimasa T, Arai H, Tamura N, Miyamoto Y, Itoh H, Nakao K. Intern Med; 1996 Jun 29; 35(6):449-52. PubMed ID: 8835594 [Abstract] [Full Text] [Related]
31. Genetic basis of phaeochromocytoma and paraganglioma. Benn DE, Robinson BG. Best Pract Res Clin Endocrinol Metab; 2006 Sep 29; 20(3):435-50. PubMed ID: 16980204 [Abstract] [Full Text] [Related]
33. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Fishbein L, Nathanson KL. Cancer Genet; 2012 Oct 01; 205(1-2):1-11. PubMed ID: 22429592 [Abstract] [Full Text] [Related]
34. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx. Gimm O. Fam Cancer; 2005 Oct 01; 4(1):17-23. PubMed ID: 15883706 [Abstract] [Full Text] [Related]
35. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. Crossey PA, Eng C, Ginalska-Malinowska M, Lennard TW, Wheeler DC, Ponder BA, Maher ER. J Med Genet; 1995 Nov 01; 32(11):885-6. PubMed ID: 8592333 [Abstract] [Full Text] [Related]
36. Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas. Chew SL, Lavender P, Jain A, Weber A, Ross RJ, Wass JA, Besser GM, Clark AJ. Clin Endocrinol (Oxf); 1995 Jan 01; 42(1):17-21. PubMed ID: 7889627 [Abstract] [Full Text] [Related]
37. Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes. Bar M, Friedman E, Jakobovitz O, Leibowitz G, Lerer I, Abeliovich D, Gross DJ. Clin Endocrinol (Oxf); 1997 Dec 01; 47(6):707-12. PubMed ID: 9497878 [Abstract] [Full Text] [Related]
38. Germ-line mutations in nonsyndromic pheochromocytoma. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peçzkowska M, Szmigielski C, Eng C, Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. N Engl J Med; 2002 May 09; 346(19):1459-66. PubMed ID: 12000816 [Abstract] [Full Text] [Related]
39. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Gupta S, Zhang J, Milosevic D, Mills JR, Grebe SK, Smith SC, Erickson LA. Endocr Pathol; 2017 Sep 09; 28(3):253-268. PubMed ID: 28646318 [Abstract] [Full Text] [Related]
40. Genetic analyses of apparently sporadic pheochromocytomas: the Rotterdam experience. Korpershoek E, Van Nederveen FH, Dannenberg H, Petri BJ, Komminoth P, Perren A, Lenders JW, Verhofstad AA, De Herder WW, De Krijger RR, Dinjens WN. Ann N Y Acad Sci; 2006 Aug 09; 1073():138-48. PubMed ID: 17102080 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]